Treatment for behavioral insomnia in young children with neurotypical development under 6 years of age: A systematic review

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews Pub Date : 2024-02-14 DOI:10.1016/j.smrv.2024.101909

Florian Lecuelle , Wendy Leslie , Marie-Paule Gustin , Patricia Franco , Benjamin Putois

{"title":"Treatment for behavioral insomnia in young children with neurotypical development under 6 years of age: A systematic review","authors":"Florian Lecuelle , Wendy Leslie , Marie-Paule Gustin , Patricia Franco , Benjamin Putois","doi":"10.1016/j.smrv.2024.101909","DOIUrl":null,"url":null,"abstract":"<div><p>This literature review examines all treatments for behavioral insomnia in children under 6 years of age to determine which treatments have empirically demonstrated efficacy. Following PRISMA guidelines, three databases were investigated (Pubmed, Cochrane and Psychinfo) to select randomized controlled trials (RCTs) which assess treatments for behavioral insomnia in children under 6 years of age, all with neurotypical development. A total of 908 articles met the search criteria. 21 articles were selected and analyzed in their entirety for a total of 2363 children (ranging from 2 months to 6 years of age). Based on these studies, treatment of behavioral insomnia in young children under 6 years of age is primarily based on behavioral therapy. There is no evidence that pharmacological treatments are effective in the long term for neurotypical children. This review highlights the lack of RCTs in this field: new RCTs should be carried out among young children to refine and optimize the therapeutic approach and to address the risk of therapeutic abuse through the use of non-scientifically validated methods.</p></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"74 ","pages":"Article 101909"},"PeriodicalIF":11.2000,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1087079224000133/pdfft?md5=c63fbcd2850287dacee4b459bb1bb2f4&pid=1-s2.0-S1087079224000133-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep Medicine Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1087079224000133","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

This literature review examines all treatments for behavioral insomnia in children under 6 years of age to determine which treatments have empirically demonstrated efficacy. Following PRISMA guidelines, three databases were investigated (Pubmed, Cochrane and Psychinfo) to select randomized controlled trials (RCTs) which assess treatments for behavioral insomnia in children under 6 years of age, all with neurotypical development. A total of 908 articles met the search criteria. 21 articles were selected and analyzed in their entirety for a total of 2363 children (ranging from 2 months to 6 years of age). Based on these studies, treatment of behavioral insomnia in young children under 6 years of age is primarily based on behavioral therapy. There is no evidence that pharmacological treatments are effective in the long term for neurotypical children. This review highlights the lack of RCTs in this field: new RCTs should be carried out among young children to refine and optimize the therapeutic approach and to address the risk of therapeutic abuse through the use of non-scientifically validated methods.

查看原文本刊更多论文

对 6 岁以下神经发育正常的幼儿进行行为性失眠治疗：系统回顾

本文献综述研究了针对 6 岁以下儿童行为性失眠的所有治疗方法，以确定哪些治疗方法具有经验证明的疗效。根据 PRISMA 指南，我们对三个数据库（Pubmed、Cochrane 和 Psychinfo）进行了调查，以筛选出评估 6 岁以下儿童行为性失眠治疗方法的随机对照试验 (RCT)。共有 908 篇文章符合检索标准。其中 21 篇文章被选中并进行了全面分析，共涉及 2363 名儿童（年龄从 2 个月到 6 岁不等）。根据这些研究，6 岁以下幼儿行为性失眠的治疗主要以行为疗法为主。没有证据表明药物治疗对神经畸形儿童长期有效。本综述强调了这一领域缺乏研究性临床试验的问题：应在幼儿中开展新的研究性临床试验，以完善和优化治疗方法，并解决因使用未经科学验证的方法而导致治疗滥用的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Sleep Medicine Reviews 医学-临床神经学

CiteScore

20.10

自引率

3.80%

发文量

107

期刊介绍： Sleep Medicine Reviews offers global coverage of sleep disorders, exploring their origins, diagnosis, treatment, and implications for related conditions at both individual and public health levels. Articles comprehensively review clinical information from peer-reviewed journals across various disciplines in sleep medicine, encompassing pulmonology, psychiatry, psychology, physiology, otolaryngology, pediatrics, geriatrics, cardiology, dentistry, nursing, neurology, and general medicine. The journal features narrative reviews, systematic reviews, and editorials addressing areas of controversy, debate, and future research within the field.